Fri, Feb 27, 2015, 4:39 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • ranger43a ranger43a Nov 25, 2012 12:00 PM Flag

    Hsp 90 Inhibitor

    Actually, not true.
    Infinity Pharmaceuticals (INFI) has an Hsp90 inhibitor-- Retaspimycin HCL. Theirs targets similar cancer patient populations as Synta's. But their market cap is double that of Synta's!!! (in part, they do have a second very promising drug, IPI-145). Synta is still quite UNDER-valued, and has a lot of room to run. Look at Infinity's yearly chart. I predict that will be our chart as well in 2013....

2.40-0.020(-0.83%)4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.